Cellosaurus CWR22Rv1-AR-EK (CVCL_WK44)
| Cell line name | CWR22Rv1-AR-EK | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | CWR22Rv1-Androgen Receptor-Exon Knockout | ||||||||||||||||||||
| Accession | CVCL_WK44 | ||||||||||||||||||||
| Resource Identification Initiative | To cite this cell line use: CWR22Rv1-AR-EK (RRID:CVCL_WK44) | ||||||||||||||||||||
| Comments | Population: Caucasian. Characteristics: Has lost the ability to express full-length AR (FL-AR), but retains that of expressing alternatively spliced forms of the AR termed AR variants (AR-Vs). Characteristics: Using CRISPR/Cas9 a stop codon was introduced downstream of the DNA-binding domain in exon 5 of the AR gene. Derived from site: In situ; Prostate; UBERON=UBERON_0002367. | ||||||||||||||||||||
| Sequence variations |
| ||||||||||||||||||||
| Disease | Prostate carcinoma (NCIt: C4863) | ||||||||||||||||||||
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||||||||||||||||
| Hierarchy | Parent: CVCL_1045 (22Rv1) | ||||||||||||||||||||
| Sex of cell | Male | ||||||||||||||||||||
| Age at sampling | Adult | ||||||||||||||||||||
| Category | Cancer cell line | ||||||||||||||||||||
| STR profile | Source(s): PubMed=31006810 Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||||
| Publications | PubMed=31006810; DOI=10.1093/nar/gkz286; PMCID=PMC6582326 | ||||||||||||||||||||
| Cross-references | |||||||||||||||||||||
| Cell line databases/resources | cancercelllines; CVCL_WK44 | ||||||||||||||||||||
| Encyclopedic resources | Wikidata; Q93464997 | ||||||||||||||||||||
| Entry history | |||||||||||||||||||||
| Entry creation | 24-May-2019 | ||||||||||||||||||||
| Last entry update | 19-Dec-2024 | ||||||||||||||||||||
| Version number | 10 | ||||||||||||||||||||